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The effect of self-efficacy expectations in the adherence to a gluten free 
diet in celiac disease 
Objective: To analyse the effect of general and specific self-efficacy on the 
adherence to a gluten free diet (GFD) in patients with celiac disease along 
with the effect of other relevant variables. 
Design: 271 patients with celiac disease participated in this transversal 
descriptive study and completed a series of questionnaires regarding 
adherence (CDAT), general self-efficacy (GSES) and specific self-efficacy 
(Celiac-SE) and CD-Qol, among others. 
Main outcome measures: Dependent variable was adherence to the Gluten 
Free Diet (GFD). Main independent variables were general self-efficacy, 
specific self-efficacy and quality of life. Model tests were conducted using 
regression analysis. 
Results: 71.9% of patients show an excellent or good adherence to the diet. 
Higher levels of adherence are positively associated to a high expectancy of 
specific self-efficacy, to the perceived adoption of recommended 
behaviours, risk perception and better quality of life (these variables 
accounted for 36.4 % of the variance in the adherence to a GFD, p<.001). 
Conclusions: Specific self-efficacy rather than general has a predictive 
value in adherence to a GFD. Therefore, we need to develop and 
transculturally adapt new instruments to assess specific self-efficacy. 
Celiac-SE has proved to be a useful scale for this objective.  







Celiac disease (CD) is a chronic small intestinal immune-mediated enteropathy 
precipitated by exposure to dietary gluten in genetically predisposed people (Ludvigsson 
et al., 2013) which hinders correct nutrient absorption. CD is one of the most common 
chronic intestinal diseases (Fasano et al., 2003). Many studies report a prevalence of 
between 1:67 and 1:250, for the USA and Europe (Leffler et al., 2008), while 1% 
prevalence is widely accepted (Catassi et al., 2007). Although there are no studies in 
Spain for any sizeable populations, prevalence is estimated between 0.26% and 0.85% 
(Arranz & Garrote, 2011). However, the variety of related clinical symptoms which this 
illness can present makes it difficult to diagnose, with a ratio 1:7 of diagnosed: 
undiagnosed cases (Farrell & Kelly, 2001). Studies indicate a female: male ratio of 2:1 
(Gujral, 2012). The only known treatment to date is to keep to a strict gluten-free diet 
(GFD) for life.  
Hall, in a systematic review (Hall, Rubin, & Charnock, 2009) highlighted the wide 
range (42-91%) of GFD adherence, depending on the definition of 'strict diet' and on its 
method of assessment. Within these wide margins, an adherence of 87% has been 
reported in the UK (Ford, Howard, & Oyebode, 2012), 50.2% in Holland (van Hees, Van 
der Does, & Giltay, 2013) and 88% in Finland (Kurppa, 2012). With regards to Spain, 
Casellas reported 82.7% (Casellas, Vivancos, & Malagelada, 2006) and (Casellas et al., 
2008) 73%. Even those studies using the same method, the Celiac Dietary Test (CDAT), 
differ in their adherence from 47.5% to 60.5% in Australia and New Zealand  (Sainsbury, 
Halmos, Knowles, Mullan, & Tye-Din, 2018; Sainsbury, Mullan, & Sharpe, 2013a; 
Sainsbury & Mullan, 2011) or 75.5% in United States (Villafuerte-Galvez et al., 2015). 
These differences show the need to unify criteria and improve the methods of estimation 
to advance towards determining the variables implied in adherence to the GFD.  
Within Social Cognitive Theory, self-efficacy refers to the belief in one’s capability to 
succeed in planning and executing specific tasks (Bandura, 1997). This expectation has 
been widely studied in many areas such as physical activity, tobacco addiction, multiple 
sclerosis, or patients with arthritis (Chiu, et al., 2011; Lorig et al., 2014; Schwarzer et al., 
2008). However, it is only in the last years that self-efficacy has been studied in the case 
of CD (Ford et al., 2012). Recent studies associated self-efficacy and control beliefs with 
a better adherence (Sainsbury & Mullan, 2011; Sainsbury et al., 2018, 2013a; Sainsbury, 
Mullan, & Sharpe, 2015). More specifically, self-regulatory efficacy (one´s confidence 
in managing GFD) and concurrent efficacy (one´s confidence in managing the life goals 
while strictly adhering to a GFD) have been revealed as important factors within the 'self-
compassion model' (Dowd & Jung, 2017). Furthermore, self-regulatory efficacy has 
proved to be a predictor of accidental (Dowd et al., 2016) or intentional gluten 
consumption (Hall, Rubin, & Charnock, 2013). Many times, these efficacy-related 
constructs differ in their definition (self-regulation or control beliefs do not always match 
self-efficacy beliefs) and on their methods of assessment (frequently appraised through 
questions designed ad hoc but not by validated questionnaires). 
Although self-efficacy was initially described as a specific construct (Bandura, 
1977), in more recent years some attempts have been made to address this belief in a 
general way (Luszczynska, Gutiérrez-Doña, & Schwarzer, 2005; Luszczynska, Scholz, 
& Schwarzer, 2005). In this context, general self-efficacy is defined as individual 
perception of his/her ability to perform successfully across a variety of different demands 
and circumstances (Judge, Erez, & Bono, 1998). This general approach has raised some 
criticism (Bandura, 2006) mainly related to its limited explanatory and predictive value 
as the items are written in a general way which may seem irrelevant for the patient. 
However, researchers have begun to face this criticism by the development of more 
rigorous psychometric studies (Scherbaum, Cohen-Charash, & Kern, 2006; Scholz et al. 
2002). These and other studies have increased the soundness of this construct and make 
worth the effort of taking into consideration general self-efficacy in research. 
As it is easier to use general self-efficacy instruments than to develop new 
instruments ad hoc, it is often general rather than specific self-efficacy that it is assessed, 
ignoring the fact that patients can have a high general self-efficacy expectation when 
dealing with their lives in general, but lack confidence when dealing with their GFD. 
Additionally, being so short, these instruments often leave out some important aspects in 
dealing with GFD, hindering intervention, as self-efficacy is very much influenced by 
situational conditions. Moreover, a patient can have strong self-efficacy beliefs while 
managing his or her GFD at home or when shopping, but they might be much lower when 
traveling. All this emphasizes, again, the need to assess self-efficacy in a specific way. 
Despite this undoubted advantage of using general self-efficacy instruments, we still 
believe that specific self-efficacy, rather than general self-efficacy, plays an important 
role in managing GFD. Therefore, it is necessary the development of specific self-efficacy 
instruments for patients with CD that take into consideration the situational circumstances 
of adhering to GFD. 
In this sense, qualitative research shows that patients with CD have to cope with 
problems mainly in five areas when dealing with their GFD (Sverker, Hensing, & Hallert, 
2005). These are: eating in the workplace, shopping, traveling, eating out and eating at 
home with others. These hardships can lead to negative feelings and affect relationships, 
which means that patients with low self-efficacy may find eating and drinking situations 
potentially stressful. Hence, some of them are not able to keep to their GFD under such 
circumstances or, if they are able to, they show a worse quality of life (Leffler et al., 
2008). As self-efficacy is much more affected by the situation, we believe that an 
assessment of specific self-efficacy in CD should consider these areas. 
In this context, the aim of this study was to investigate the role of general and 
specific self-efficacy and their relationship with other psychosocial variables that can 
affect adherence to a GFD in patients with CD. Namely, quality of life, perceived 
adherence to recommended behaviours, risk perception, intensity of symptomatology, 
perceived consequences of abandoning the diet, age, age at diagnosis, and time since 
diagnosis. More specifically, it was hypothesized that both general and specific self-
efficacy would play an important role in adhering to a GFD and that specific self-efficacy 
would be a better predictor of adherence than general self-efficacy. Finally, we expected 
to find differences in specific self-efficacy and adherence to GFD in those patients who 
have been dealing with a firm diagnosis for a longer period. 
2. Materials and Methods  
The study population was made up of individuals with CD from the only patients’ 
association in the region of Aragon (Spain). The inclusion criteria were to be 18 years or 
over, to have a firm diagnosis of CD and to have been prescribed a strict GFD for life. 
These criteria were established by responding affirmatively to three self-reported 
questions. 
A test battery was designed to analyse the relationship between adherence to a 
GFD, self-efficacy expectation, quality of life, the perceived adoption of recommended 
behaviours and risk perception in patients with CD, along with other sociodemographic 
variables. The questionnaires were distributed online and on paper to 1,882 members of 
the main patients’ association in the region. After receiving written information about the 
study, the patients completed an informed consent document. The SPSS v.21 program 
was used for the statistical analysis. Descriptive analysis was conducted and t- Student 
and Chi squared tests were calculated in order to examine the differences in adherence to 
a GFD. Various linear regression analyses were performed to analyse GFD adherence. 
Statistically significant differences were set at p < 0.05. 
This research was approved by the Ethics Committee of Research of Aragon 
(CEICA) registered under number PI 14/0011. 
2.1 Adherence to a GFD 
GFD adherence was estimated through the CDAT questionnaire (D. Leffler et al., 2009). 
The questionnaire is made up of seven questions. It is easy to apply and has good 
psychometric properties. According to the author’s studies, it also offers the advantage of 
correlating with serological and histological variables, as well as with interviews with 
dieticians. The questionnaire was translated into Spanish for the purposes of this study 
and this version again presents good psychometric properties (Fueyo et al., 2016). 
Patients are asked to answer the seven items on a 5-point Likert scale. Scores are additive 
(7-35), with higher scores indicating lower adherence. Following the author’s 
recommendations, scores below 13 are deemed to represent excellent or very good 
adherence, 13-17 moderate adherence, whereas scores greater than 17 show fair to poor 
adherence (Leffler et al., 2009). 
2.2 General and specific self-efficacy  
General self-efficacy was evaluated using a Spanish adaptation of the GSE scale (Baessler 
& Schwarzer, 1996). The scale comprises ten questions in which the patient is asked to 
answer items of the type, “I can solve difficult problems if I make enough effort” on a 4-
point Likert scale (not at all true, hardly true, moderately true, exactly true). Scores are 
accumulative and range between 10 and 40, with higher scores indicating greater self-
efficacy. 
Specific self-efficacy was evaluated using the Celiac-SE scale, which was 
developed and validated as part of this research (Fueyo-Díaz et al., 2018) to measure the 
degree of adherence to a GFD in patients aged 12 years and over in different situations, 
such as shopping, eating at home with others, traveling, eating out or eating in the 
workplace or at school. A 20-question scale was used in which patients rated items from 
0 (I could definitely not do this) to 10 (I am completely certain I could do this). The 
questionnaire gives a mean overall score for the whole scale and for each of the areas 
explored. Scores above seven are indicative of high specific self-efficacy. The 
Cronbach´s alpha for the scale was 0.81 and between 0.64 and 0.91 for each factor.  
2.3 Quality of life 
Quality of life of patients with CD was evaluated using the Celiac Disease Quality of life 
(CD-QoL) survey (Dorn et al., 2010) in its adapted Spanish version (Casellas et al., 
2013a). This questionnaire contains 20 questions that are answered on a 5-point Likert 
type scale. Scores are additive from 10 to 100 points, with higher scores reflecting a 
higher quality of life. Scores of 70 and above are considered to be indicative of a high 
quality of life (Casellas et al., 2013b). The questions are grouped into four sections: 
limitations, dysphoria, health problems and inappropriate treatment. 
2.4 Risk perception, perceived adoption of recommended behaviours, time since 
diagnosis and others 
Simultaneously, we evaluated risk perception and perceived adherence to behaviours 
recommended by patient associations (FACE, 2015). Fifteen questions were scored from 
zero to 10 according to the risk perceived and from zero to 10 depending on whether the 
recommended behaviour was adopted or not. Scores were additive for each category with 
higher scores indicating a more perceived serious risk and a closer perceived adherence 
to recommended behaviours. Examples of these items were: ‘I consider being a risk 
consuming processed products without a gluten free label’, ‘consuming products without 
checking the label’ or ‘not eliminating bulk products from diet’. The same item was 
evaluated as a risk (not risky- very risky) and as an adopted behaviour (I avoid this 
behaviour- I do not avoid this behaviour. Other issues studied include experience with 
the disease (time since diagnosis), and self-reported questions about perceived 
consequences for abandoning the diet or transgressing (1: No consequences - 5: very 
severe consequences) or the presence of digestive or non-digestive symptoms before 
diagnosis or associated diseases. 
2.5 Socio-demographic variables 
Finally, we incorporated a series of socio-demographic variables related to age, residence, 
gender, nationality, marital status, work situation and education. 
3. Results 
Three hundred and thirty-nine questionnaires (18.01%) were collected, of which 271 
corresponded to patients with CD, 22 were gluten sensitive and 46 others did not fulfil 
the age requirements or were uncompleted. 
3.1 Description of the sample 
Of the 271 patients with CD (15.6% male; 84.4% female), 89.3% declared that they 
belonged to a patients' association and 10.7% did not. Ages ranged from 18 to 72 years 
(M = 40.15; SD = 11.92). Most of the participants had several years of experience with 
the disease (M = 7.61; SD = 8.39). Main characteristics of the sample are shown in table 
1 while main results related to psychosocial factors are shown in table 2. 
<Insert table 1> 
3.2 Data analysis 
We compared high and moderate/low adherence groups for the following variables: 
general self-efficacy (GSES), specific self-efficacy (Celiac-SE), quality of life (CD-
QoL), recommended behaviours, risks, intensity of symptoms, consequences of 
abandoning, age, age at diagnosis, time since diagnosis and gender. The variables 
included in the linear regression were those significant from the univariate analysis. Risk 
perception was included although it was not significant due to the relationship it has with 
self-efficacy beliefs. We use a linear regression analysis to study the role of these 
variables in adherence to a GFD. 
 <Insert table 2> 
3.3 Adherence to GFD 
The results of the CDAT showed very good adherence (M = 11.56, SD = 2.99). 71.9% 
showed excellent or good adherence to the diet, with scores below 13, while 4.5% 
declared poor adherence, with scores above 17. Table 3 shows differences between the 
high adherence group (individuals with excellent or very good adherence, with score < 
13) and the moderate/low adherence group (individuals with moderate, poor and fair 
adherence, with scores ≥ 13) with any of the psychological factors studied. No differences 
were found for gender or age.  
<Insert table 3> 
3.4 Self-efficacy  
Participants showed a high general self-efficacy (M = 31.19; SD = 5.31) and we found 
differences between the high and moderate/low adherence groups (p = .021). Regarding 
specific self-efficacy, we found differences between the high and moderate/low 
adherence groups, showing those participants with better adherence to a GFD to have a 
higher specific self-efficacy expectation (p < 0.001). Generally, individuals showed high 
specific self-efficacy when dealing with their GFD for the total score (M = 8.60; SD = 
1.66). In a more detailed analysis by areas (Table 2), we found the lowest specific self-
efficacy for traveling (8.06), followed by eating out (8.48), shopping (8.49), and at work 
or school (8.58). Eating at home with others showed the highest self-efficacy (9.21). We 
found differences p < .001 between all of them except for shopping and eating out (p = 
0,981), shopping and eating at work (p =0,279) and eating out and at work (p = 0,213). 
We also found differences for each of these areas between high and moderate/low 
adherence groups (Table 4). No differences were found in either variable for gender. 
12.2% show a specific self-efficacy score for shopping of 7 or below, 23% for traveling, 
8.7% for eating with others at home, 17.5% for eating outside with others and 18.3% for 
adhering to a GFD at work. 
<Insert table 4> 
3.5 Quality of life 
The results in CD-QoL showed a good quality of life (M = 75.88, SD = 15.16). 30.8% of 
patients scored below a direct score of 70. The dimensions most affected were inadequate 
treatment (M = 6.90) and health concerns (M = 17.14). Significant differences were found 
between the high and moderate/low adherence groups for the whole scale (p < 0.001), 
with those participants with a better adherence to a GFD perceiving themselves to have a 
better quality of life. No differences were found for gender. 
3.6 Intensity of symptoms and risk perception. 
High and moderate/low adherence groups showed no differences in terms of the 
consequences of abandoning the diet (p = .079) and in relation to risk evaluation (p = 
.074) of following or not following the recommended behaviours. However, it seems 
clear that patients who perceive themselves to follow the recommended behaviours have 
a better adherence to GFD in the CDAT (p < .001). 
3.7 Age at diagnosis and time since diagnosis 
Age at diagnosis and time since diagnosis do not appear to have an important role in the 
degree of GFD adherence. 
3.8 Relationship between the variables and GFD 
Table 5 shows the results of a linear regression to determine the impact of changes in the 
independent variables on the adherence to a GFD. After studying the main variables, we 
only show those that have very clear effects: specific self-efficacy in coping with the 
disease, perceived adoption of recommendations of the patients’ associations and quality 
of life, all of which are significant. We include risk perception due to the importance that 
risks play in self-efficacy beliefs. The model with these four variables accounted for 36.4 
% of the variance in the adherence to a GFD. As far as semi-partial correlations are 
concerned, recommended behaviours accounts for 15.3 %, quality of life accounts for 
6.7%, risk perception accounts for 3.7% whereas specific self-efficacy accounts for 1.8%. 
This means that the higher the specific self-efficacy beliefs, the better the quality of life, 
the higher risk perception and the stronger the perceived compliance with the 
recommended behaviours, the better the adherence to a GFD. 
 
<Insert table 5> 
The correlation matrix shows that adherence to GFD correlates with specific self-
efficacy, risk perception, quality of life and the perceived adoption of recommended 
behaviours, all of them significant (p < .01). We observe a high correlation (0.630) 
between following the recommendations for a GFD and risk perception. It seems logical 
that those who perceive a more important risk in not adopting a preventive behaviour are 
those who believe that they adopt that recommended behaviour.  
The relationship between specific self-efficacy and risk perception is high (.545) 
and significant (Cohen, 1988), showing that the higher perceived risk the higher self-
efficacy. There is also a correlation between quality of life and specific self-efficacy (p = 
.000) showing that those with a higher specific self-efficacy have a better quality of life. 
There is a significant (p<.01) correlation between specific self-efficacy and the perceived 
adoption of recommended behaviours (0.361). Finally, the matrix shows no relationship 
between quality of life and risk perception or the perceived adoption of the recommended 
behaviours.  The full correlation matrix has been added in text as table 6 (dependent 
variable has been also included in correlation table).  
We observe a significant correlation between the studied variables and adherence: 
the perception of following the recommended behaviours correlates with a better 
adherence (-.469), a better quality of life is related to a better adherence (-.387) and, a 
specific self-efficacy correlates with a higher adherence (-.318). Finally, regarding risk 
perception this correlation is low but significant (-.191). 
<Insert table 6> 
Age, age when diagnosed, time since diagnosis, intensity of symptoms or the 
belief in serious consequences of abandoning the GFD were not predictive to adherence. 
4. Discussion 
This research shows that elements such as self-efficacy, perceived quality of life, risk 
perception and the perceived adoption of recommended behaviours play an important role 
in adhering to GFD in patients with CD. Moreover, it is self-efficacy assessed in a specific 
way, rather than in a general one, which is important for predicting this adherence. 
4.1 Adherence to GFD 
Adherence to a GFD was high in the research, with 71.9% showing excellent or good 
adherence according to the criteria of Leffler (Leffler et al., 2009) and within the range 
of the systematic review made by Hall (N J Hall et al., 2009). The frequent high adherence 
found in research may be because in most cases the questions are self-informed with no 
physiological correlates. Furthermore, many studies are carried out through associations 
of patients which are made up precisely of better prepared people who are also more 
motivated to observe the diet (Butterworth, 2004; Hall et al., 2009; Leffler et al., 2008). 
In our study, this adherence to GFD is related to specific self-efficacy, quality of life, risk 
perception and the perceived adoption of recommendable behaviours. 
We must note that general self-efficacy was significant in the univariate analysis 
and not in the regression analysis. According to the original definition of self-efficacy 
expectation (Bandura, 1997), self-efficacy has to be measured in a specific way taking 
into account the situation (Bandura, 2006). This fact may explain why a general measure 
does not predict the adherence. Perceived risks are included in the model as they play a 
role through self-efficacy expectations. According to Social Cognitive Theory, patients 
with high self-efficacy expectations see risks as a challenges, whereas patients with lower 
self-efficacy expectations see them as a potential threat (Bandura, 1997), hindering their 
adherence and, hence, their quality of life. In contrast to other studies (Ford et al., 2012; 
Kurppa et al., 2012), no relationship is found with age, age when diagnosed, time since 
diagnosis or gender.  
The definition of strict adherence and the way GFD adherence is measured varies 
from some studies to others (Hall et al., 2013). The difficulty of finding sensitive, specific 
methods has led researchers to use self-informed questions, rather than to establish 
objective criteria to assess adherence to a GFD. These subjective methods may be 
moderated by the patients' correct or erroneous knowledge of the disease and by their 
appropriate or inappropriate assessment of the risks. On the other hand, although it seems 
obvious that any tool that is developed will need to present some correlates between 
adherence and the objective state of health, histological and serological measures are 
expensive and invasive and lack sensitivity in detecting occasional transgressions from 
the diet (Leffler et al., 2007). Dietetic evaluations (Leffler et al., 2007; Ludvigsson et al., 
2014) and immunogenic peptides (Comino et al., 2012; Moreno et al., 2017) have proved 
to be effective in the celiac disease follow-up. Therefore, it is necessary to develop, 
validate and transculturally adapt new instruments that base evaluation of adherence on 
patients’ knowledge, expectations, risk behaviours and state of health in order to measure 
adherence effectively. These methods should also be properly correlated with 
physiological variables of adherence. 
4.2 Self-efficacy 
General and specific levels of self-efficacy are high in the sample with no gender 
differences. Indeed, the general self-efficacy levels are significantly high compared to 
those published in previous studies (Scholz et al., 2002). This would support the idea put 
forward by other authors (Bellini et al., 2011) that patients with CD may develop a more 
internal locus of control than occurs in other chronic illnesses, since in CD control lies 
more in the hands of the patient than in those of the doctor. In other words, adherence to 
their treatment demands greater responsibility in the management of their disease from 
patients with CD than it does in other chronic diseases where doctors lead their treatment. 
We believe that this fact instils stronger self-efficacy beliefs in patients with CD, not only 
specific but also general ones. According to the results here, the expectation of specific 
self-efficacy plays an important role in adherence to the GFD, while general self-efficacy 
is not so important. This fact reinforces the arguments in favour of an evaluation of 
specific self-efficacy in contrast to a general one as a better predictor of future behaviour 
(Bandura, 1997) and more useful to design new programs to improve adherence. 
Regarding health behaviour, previous research on self-efficacy often assessed control 
beliefs in a general way (Luszczynska, Gutiérrez-Doña, et al., 2005; Luszczynska, 
Scholz, et al., 2005; Schwarzer et al., 2008). Concerning GFD adherence, when self-
efficacy is assessed in a specific way, studies differ in its definition and method of 
assessment (Dowd et al., 2016; Lorig et al., 2014; Sainsbury et al., 2018; Sainsbury & 
Mullan, 2011) which frequently leaves out the influence of situation. We found 
differences not only between high and moderate/low adherence groups, but also among 
the different areas assessed by Celiac-SE. Therefore, it is necessary to develop new 
instruments to assess specific self-efficacy for different domains of life, and more 
specifically in dealing with GFD. Celiac-SE has proved to be a useful instrument in this 
context and we believe it can be very useful in clinical settings where it can help to 
identify patients with low self-efficacy for certain domains of GFD. Using Social 
Cognitive Theory as a framework for the design of interventions will allow us to increase 
specific self-efficacy through well-known sources such as previous accomplishments, 
modelling, verbal persuasion or the self-evaluation of physiological and affective states 
(Bandura, 1997) increasing its operational power to increase adherence to GFD. 
Finally, although we expected variables related to time, such as age, age when 
diagnosed, years since diagnosis, to have played a major role in developing specific self-
efficacy and hence, adherence to GFD, we found no relationship. This could be explained, 
within the framework of Social Cognitive Theory, as it is positive experiences in coping 
with the disease that are responsible for the development of specific self-efficacy and not 
the mere passage of time. 
4.3 Quality of life 
The results from the CD-QoL indicate a good quality of life in patients with CD, with the 
issues that are most affected being health problems and the perception of unsuitable 
treatment, as found in other studies (Casellas et al., 2013b). Nevertheless, we need to note 
that an important number of individuals (30.8%) are below the recommended cut-off 
point of 70 which shows good quality of life (Casellas et al., 2013b).  
According to the linear analyses, quality of life is a predictor of adherence to GFD. 
Moreover, quality of life may affect adherence at the same time, because it seems logical 
that people who adhere to a GFD, with disappearance of symptoms, improve their quality 
of life. On the other hand, when quality of life gets worse they are prone to abandon the 
diet. The alterations in both mood and quality of life may lead to a GFD abandonment. 
That is why we think that quality of life may play an important role in adherence to a 
GFD as depressive symptoms and other psychiatric conditions may affect adherence and 
vice versa (Sainsbury, Mullan, & Sharpe, 2013b; Sainsbury et al., 2013a; van Hees et al., 
2013; Zarkadas et al., 2013). 
This study has several limitations: firstly, participants were recruited through a 
patients' association which might affect their knowledge or awareness of the disease and 
their adherence to a GFD. Secondly, although in order to become a member, they are 
interviewed by an expert dietitian, they were included in the sample after responding 
affirmatively to the questions related to having a firm CD diagnosis and being prescribed 
a GFD for life. Therefore, CD was not confirmed with concurrent histological evaluation. 
Finally, being a long and online survey may have affected the number of completely 
answered questionnaires that were returned.  
Future research should focus on distinguishing specific self-efficacy expectations 
at different moments in adhering to a GFD. New instruments should be developed, for 
example, to differentiate among action, maintenance and recovery self-efficacy 
(Schwarzer, Lippke, & Luszczynska, 2011) as useful constructs to ensure a lifelong 
adherence. Additionally, it will be interesting to study the impact of these psychosocial 
variables on quality of life in the future. The Social Cognitive Theory offers a theoretical 
framework for research and to develop programs to improve adherence and quality of life 
of chronic patients in clinical settings (Lorig et al., 1999; Lorig, 1993, 1996). These 
programs can be adapted to patients with CD and can, moreover, constitute an important 
saving when they are addressed as a part of primary health care (Ahn et al., 2013; 
Bodenheimer, Lorig, Holman, & Grumbach, 2002). 
5. Conclusions  
Specific self-efficacy expectation, quality of life, risk perception and the perceived 
adoption of the behaviours recommended by patients' associations play an important role 
in adherence to GFD and these factors need to be addressed in clinical settings to improve 
adherence. Specific self-efficacy rather than general self-efficacy has a predictive value 
in adherence to a GFD. Therefore, we need to develop and transculturally adapt new 
instruments to assess specific self-efficacy. Celiac-SE has proved to be a useful 
questionnaire for this objective. Identifying the factors behind high adherence to a GFD 
will enable the design of programs to improve adherence and, subsequently, quality of 
life in patients with CD. 
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Mean age ± standard deviation (years) 40.15 ± 11.92 
Gender (% female) 84.4  
Mean age at diagnosis ± standard deviation (years) 31.52 ± 14.09 
Mean time since diagnosis ± standard deviation (years) 7.61 ± 8.39  
Associated to a support group (%) 89.3 
Nationality (% Spanish) 99.3 
Civil status (% married/single/divorced/other) 72.7/22.9/3.40/1 
Self-reported gluten-free diet adherence (% strict) 95.1 
Intensity of symptoms after transgressions 
(%none/mild/moderate /intense/very intense) 
19.8/23.6/23.6/2
2.9/10.1 
Associated diseases (%) 42.8 
Education (% primary/secondary/university/other)  5.6/28.4/63.5/2.5 
Years with symptoms before diagnosis (% 0/<1/1-5/>5) 7/17/19.6/0.7/45 
Presence of digestive symptoms before diagnosis (%) 74.5 









 N Minimum Maximum Mean SD 
Adherence to GFD  263 7 2 11.56 2.99 
General self-efficacy 261 13 40 31.19 5.31 
Specific self-efficacy  239 1.66 10 8.60 1.66 
Shopping 263 2.50 10 8.49 1.68 
Traveling 265 0 10 8.06 2.27 
Eating at home with others 258 0 10 9.21 1.80 
Eating outside with others 263 0 10 8.48 1.92 
At work or Studies 262 0 10 8.58 2.14 
Age at diagnosis 251 0 71 31.52 14.09 
Intensity of symptoms 258 1 5 2.80 1.28 
Consequences of abandoning 259 1 5 1.44 .70 
Time since diagnosis 251 0 42 7.61 8.39 
Quality of Life (CD-QoL) 253 25 100 75.88 15.16 
Limitations 254 10 45 34.45 7.92 
Dysphoria 261 5 20.00 17.50 2.94 
Health concerns 261 5 25.00 17.14 5.01 
Inadequate treatment 263 2 10.00 6.90 1.79 
Perceived adoption of 
recommended behaviours 
233 0 150.00 132.62 21.07 





Table 3. Factors associated with high or moderate/low adherence to a gluten-free diet 
 
 Adherence N Mean SD p 
General self-efficacy  Moderate/Low 113 30.86 5.72 .021* High 42 31.51 4.87  
Specific self-efficacy  Moderate/Low 99 8.15 1.80 .000** High 136 8.91 1.30  
Quality of life  Moderate/Low 105 70.78 16.25 .000** High 144 79.77 13.19  
Perceived adoption of recommended 
behaviours 
Moderate/Low 115 147.70 29.69 .001** 
High 118 161.22 20.47  
Risk perception Moderate/Low 115 148.40 28.24 .115 High 148 154.75 28.64  
Intensity of symptoms Moderate/Low 109 2.87 1.26 .300 High 144 2.74 1.29  
Consequences of abandoning Moderate/Low 109 1.55 .78 .079 High 145 1.36 .63  
Age Moderate/Low 115 39.10 12.23 .677 High 148 40.28 11.49  
Age when diagnosed Moderate/Low 106 31.58 13.60 .710 High 139 30.91 14.35  
Time since diagnosis Moderate/Low 106 6.45 7.45 .125 High 139 8.51 9.11  
Gender Moderate/Low 147 0.81 .40 .561 High 114 0.87 .34  
* Significant at p<0.05; ** Significant at p<0.01. High adherence group with CDAT scores <13 and 
moderate/low adherence group with CDAT scores ≥13. A chi-square test was performed for variable 
gender. 
  
Table 4. Specific self-efficacy in adherence to GFD 
 
 Adherence N Mean SD p 
Shopping Moderate/Low 72 7.77 1.92 .000** High 186 8.77 1.50  
Traveling Moderate/Low 72 6.95 2.58 .000** High 187 8.44 2.01  
Eating at home with others Moderate/Low 70 8.73 2.15 .025* High 182 9.38 1.65  
Eating outside with others Moderate/Low 71 7.65 2.22 .000** High 185 8.79 1.72  
At work or studies Moderate/Low 72 7.74 2.57 .001** High 184 8.90 1.86  
Overall Scale Moderate/Low 63 7.86 1.87 .000** High 172 8.85 1.51  
* Significant at p<0.05; ** Significant at p<0.01 
 
  
Table 5. Linear regression analysis predicting GFD adherence. 
 
Variable B β R2 (∆) F 
 Specific Self-efficacy -0.322 -0.171* .364 38.13** 
 Recommended behaviours  -0.077 -0.512**   
 Quality of life -0.057 -0.283**   
Risk perception 0.030 0.206*   
      
*p<.01, ** p<.001 
 
  













 Adherence GFD 1 -.469* -.387* -.191* -.318* 
 Recommended behaviours  -.469* 1 .089 .630* .361* 
 Quality of life -.387* .089 1 -.065 .263* 
Risk perception -.191* .630* -.065 1 .545* 
 Specific Self-efficacy  -.318* .361* .263* .545* 1 
 
* p≤ .001 
 
 
 
 
